Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well thalidomide works in treating patients with
carcinosarcoma of the uterus that has come back or that does not go to remission (decrease or
disappear but may still be in the body) despite treatment. Thalidomide may stop the growth of
cancer by stopping blood flow to the tumor.